Dermapharm Holding SE
XHAM:DMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dermapharm Holding SE
XHAM:DMP
|
DE |
|
Prysmian SpA
F:AEU0
|
IT |
|
N
|
Netscout Systems Inc
SWB:NSZ
|
US |
|
H
|
Hapag-Lloyd AG
DUS:HLAG
|
DE |
|
Dufry AG
OTC:DUFRY
|
CH |
|
B
|
BP PLC
XMUN:BPE5
|
UK |
|
M
|
Medtronic PLC
DUS:2M6
|
IE |
Wall St Price Targets
DMP Price Targets Summary
Dermapharm Holding SE
According to Wall Street analysts, the average 1-year price target for DMP is 53.16 EUR with a low forecast of 46.32 EUR and a high forecast of 65.67 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DMP's stock price target?
Price Target
53.16
EUR
According to Wall Street analysts, the average 1-year price target for DMP is 53.16 EUR with a low forecast of 46.32 EUR and a high forecast of 65.67 EUR.
What is the Revenue forecast for Dermapharm Holding SE?
Projected CAGR
5%
Over the last 10 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 5 years is 5%.
What is the Gross Profit forecast for Dermapharm Holding SE?
Projected CAGR
4%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Dermapharm Holding SE?
Projected CAGR
6%
Over the last 10 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 6%.
What is the Pre-Tax Income forecast for Dermapharm Holding SE?
Projected CAGR
10%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 10%.
What is the Net Income forecast for Dermapharm Holding SE?
Projected CAGR
9%
Over the last 10 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 3 years is 9%.
